New EU guidance on registry-based studies
The European Medicines Agency (EMA) has published new guidance on generating evidence from patient registries. The publication aims to increase the quality of research using the wealth of […]
The European Medicines Agency (EMA) has published new guidance on generating evidence from patient registries. The publication aims to increase the quality of research using the wealth of […]
Medicines approved by the European Medicines Agency (EMA) to treat one illness could be repurposed by academics and non-governmental organisations as therapies for other illnesses, as part of […]
Pharmacists and pharmacy technicians are set to benefit from a further investment of up to £15.9m over the next four years. This investment, announced by Health Education England […]
Ministers are announcing action to prevent medicines being prescribed unnecessarily, following a new review led by Dr Keith Ridge CBE, Chief Pharmaceutical Officer for England. The review of […]
The clock is ticking down to the ‘go-live’ date for the EU’s new Clinical Trials Information System (CTIS) which will roll out on 31 January 2022. The European […]
The success rate for marketing authorisation applications for small and medium-sized enterprises (SMEs) has doubled between 2016 and 2020, according to the European Medicines Agency (EMA). In 2016, […]
The European Medicines Agency gave its backing to 15 new medicines at its December meeting, taking its total for the year to 96. This rounded off a busy […]